Skip to main content
logo
Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.708
-0.077 (-2.76%)
Apr 24, 2026, 1:02 PM EDT - Market open

Cellectar Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Cap
111451,71514,4443,629,4158,506,879
Market Cap Growth
3.45%-99.97%258.04%-99.60%-57.34%347.54%
Enterprise Value
-0.98-7.1151,71214,4263,629,3818,506,842
Last Close Price
2.718.9783.1051.30198.00624.00
PE Ratio
--0.21-0.79-0.38-1.52-2.74
PB Ratio
1.470.96-3411.521771.56109831.99155250.52
P/TBV Ratio
0.650.78-2.231.481.110.75
P/FCF Ratio
--0.29-1555.76-567.58-159814.32-607847.13
P/OCF Ratio
--0.29-1597.28-572.67-160815.33-610567.41
EV/EBITDA Ratio
-0.14-1333.88-503.26-151341.72-561548.65
EV/EBIT Ratio
-0.14-1327.29-500.67-150401.51-556353.69
EV/FCF Ratio
-0.15-1555.67-566.88-159812.82-607844.50
Debt / Equity Ratio
0.050.03-0.040.060.010.01
Debt / EBITDA Ratio
-0.01-0.01-0.01-0.02-0.01-0.03
Debt / FCF Ratio
-0.01-0.01-0.02-0.02-0.01-0.03
Net Debt / Equity Ratio
-1.52-1.590.59-2.36-1.07-1.04
Net Debt / EBITDA Ratio
0.410.440.230.671.483.75
Net Debt / FCF Ratio
0.410.480.270.761.564.06
Quick Ratio
2.562.480.381.738.9516.04
Current Ratio
2.772.580.411.789.1616.26
Return on Equity (ROE)
-150.47%-4693.38%2016.68%-149.33%-54.92%-47.28%
Return on Assets (ROA)
-149.79%-275.37%-231.78%-98.20%-50.35%-43.13%
Return on Invested Capital (ROIC)
818.22%856.83%748.63%944.62%1120.75%1027.24%
Return on Capital Employed (ROCE)
-232.81%-3693.99%2439.08%-133.09%-54.65%-47.36%
Earnings Yield
-184.53%-467.00%-126.34%-263.74%-65.91%-36.54%
FCF Yield
-195.82%-346.11%-0.06%-0.18%-0.00%-0.00%
Buyback Yield / Dilution
-110.67%-203.92%-73.22%-27.09%-180.20%-158.14%
Total Shareholder Return
-110.67%-203.92%-73.22%-27.09%-180.20%-158.14%
Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q